Strides Arcolab Ltd’s tablets and capsules facility in its oncology medicine complex had received European regulatory approval. It expected to take two products to Europe during the July-September third quarter this year. The oral dosages facility is part of Onco Therapies Ltd, the cancer drugs arm under Strides subsidiary, Agila Specialities. OTL's injectables facility is already approved by major regulatory agencies, enabling Strides to sell its products in many overseas markets. In Europe, it has made 18 filings for oncology products that have potential local sales of $3.2 billion.crackcrack
